Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
11445 | 914 | 34.3 | 52% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
202 | 20434 | CLOPIDOGREL//PRASUGREL//ASPIRIN RESISTANCE |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | DIABETOL DDG | Address | 2 | 67% | 0% | 2 |
2 | JOHN COOK RENAL UNIT | Address | 2 | 67% | 0% | 2 |
3 | PLATELET HYPERSENSITIVITY | Author keyword | 2 | 67% | 0% | 2 |
4 | PLATELET MEMBRANE LIPIDS | Author keyword | 2 | 67% | 0% | 2 |
5 | FACTOR VIII C | Author keyword | 2 | 43% | 0% | 3 |
6 | PLATELET MEMBRANE LIPID FLUIDITY | Author keyword | 1 | 100% | 0% | 2 |
7 | HAEMOSTASIS HAEMOSTAT DISORDERS | Address | 1 | 11% | 1% | 8 |
8 | LIAIT | Address | 1 | 21% | 0% | 3 |
9 | ABORATING DIABET TREATMENT PREVENT | Address | 1 | 50% | 0% | 1 |
10 | ABT ENDOKRINOL DIABETOL ANGIOL NEPHROL KLIN C | Address | 1 | 50% | 0% | 1 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CELL LINE MEG 01 | 6 | 80% | 0% | 4 |
2 | RETINAL VASCULAR PATTERN | 4 | 75% | 0% | 3 |
3 | DECREASED VASCULAR PROSTACYCLIN | 2 | 29% | 1% | 5 |
4 | NEAR NORMOGLYCEMIC CONTROL | 2 | 43% | 0% | 3 |
5 | INCREASED PLATELET AGGREGATION | 1 | 50% | 0% | 2 |
6 | REDUCED MEMBRANE FLUIDITY | 1 | 100% | 0% | 2 |
7 | VONWILLEBRAND FACTOR ACTIVITY | 1 | 50% | 0% | 2 |
8 | THROMBOXANE SYNTHASE INHIBITOR | 1 | 25% | 0% | 4 |
9 | ANTITHROMBIN III ACTIVITY | 1 | 16% | 1% | 6 |
10 | MEMBRANE LIPID FLUIDITY | 1 | 22% | 0% | 4 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
FACTORS OF THE HEMOSTATIC SYSTEM IN DIABETIC-PATIENTS - A SURVEY OF CONTROLLED-STUDIES | 1986 | 179 | 94 | 80% |
COAGULATION ACTIVATION IN DIABETES-MELLITUS - THE ROLE OF HYPERGLYCEMIA AND THERAPEUTIC PROSPECTS | 1993 | 185 | 79 | 42% |
Platelet dysfunction in type 2 diabetes | 2001 | 211 | 90 | 36% |
The platelet in diabetes - Focus on prevention of ischemic events | 2003 | 148 | 47 | 23% |
Overview of Platelet Physiology: Its Hemostatic and Nonhemostatic Role in Disease Pathogenesis | 2014 | 4 | 123 | 17% |
The role of platelets in diabetes-related vascular complications | 2000 | 60 | 125 | 31% |
Diabetes-associated macrovasculopathy: pathophysiology and pathogenesis | 2007 | 62 | 119 | 13% |
Platelet signalling abnormalities in patients with type 2 diabetes mellitus: A review | 2008 | 20 | 72 | 21% |
PLATELET-FUNCTION, PLATELET PROSTANOIDS AND VASCULAR PROSTACYCLIN IN DIABETES-MELLITUS | 1989 | 47 | 109 | 64% |
Blood platelet reactivity and its pharmacological modulation in (People with) diabetes mellitus | 2005 | 44 | 297 | 26% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | DIABETOL DDG | 2 | 67% | 0.2% | 2 |
2 | JOHN COOK RENAL UNIT | 2 | 67% | 0.2% | 2 |
3 | HAEMOSTASIS HAEMOSTAT DISORDERS | 1 | 11% | 0.9% | 8 |
4 | LIAIT | 1 | 21% | 0.3% | 3 |
5 | ABORATING DIABET TREATMENT PREVENT | 1 | 50% | 0.1% | 1 |
6 | ABT ENDOKRINOL DIABETOL ANGIOL NEPHROL KLIN C | 1 | 50% | 0.1% | 1 |
7 | ADV MED DENTAL | 1 | 50% | 0.1% | 1 |
8 | CELLULAR HEMOSTASIS CLIN ANGIOL GRP | 1 | 50% | 0.1% | 1 |
9 | DRUGS BIOL | 1 | 50% | 0.1% | 1 |
10 | LIPHA U352 | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000144917 | COAGULATION ABNORMALITY//D L LYSINACETYLSALICYLATE//SECT CLIN GERONTOL VASC MED |
2 | 0.0000126933 | GLICLAZIDE//INTERNAL MED DIABETOL CLIN PHARMACOL//DRUG QUAL CONTROL PHARMACOVIGILANC |
3 | 0.0000125737 | PROSTACYCLIN STIMULATING FACTOR//CANINE PLATELET//CELLULAR METABOLITES |
4 | 0.0000111840 | DERMCIDIN ISOFORM 2//ACUTE ISCHEMIC HEART DISEASE//GEA 3175 |
5 | 0.0000099798 | SPONTANEOUS PLATELET AGGREGATION//PARTICLE COUNTING METHOD//AGGREGOMETER |
6 | 0.0000097442 | LONG CHAIN FATTY ACYL COA SYNTHETASE//ARACHIDONIC ACID BIOSYNTHESIS//DELTA 6 DESATURASE ACTIVITY |
7 | 0.0000096430 | RECEPTOR C K//PLATELET THROMBOXANE FORMATION//REFLECTION CONTRAST MICROSCOPY |
8 | 0.0000090664 | PHYSIOL MORPHOL//RAT AORTAE//CHARLIE NORWOOD VET ADM MED |
9 | 0.0000082018 | ANTITHROMBUS//GUINEACORN//TRICLYCERIDE |
10 | 0.0000080385 | MEAN PLATELET VOLUME//PLATELET DISTRIBUTION WIDTH//PLATELET INDICES |